Designer drugs – still a threat? / Narkotyki projektowane (dopalacze) czy nadal są zagrożeniem?
Journal Title: Przegląd Epidemiologiczny - Year 2019, Vol 73, Issue 3
Abstract
INTRODUCTION. In Poland, an increasing number of psychoactive substances are becoming prohibited by law as psychotropic or narcotic substances, or as new psychoactive substances (NPSs). Owing to the enormous technological possibilities offered by today’s science, synthesis of new derivatives of prohibited compounds is no longer a problem. The moment a dangerous substance is outlawed, new designer drugs (in Poland known as ‘dopalacze’) appear on the market. STATE OF KNOWLEDGE. An amendment to the Act on Counteracting Drug Addiction issued in July 2018 made it possible for the NPS to be considered drugs by law. Synthetic cannabinoids and cathinone derivatives make up the majority of NPSs identified by the authorities in Poland. Synthetic cannabinoids which can, unlike cannabinoid receptor agonists of plant origin, cause death by somatic toxicity, are particularly dangerous. The ability to quickly recognize poisoning with synthetic opioids is crucial, since an antidote reversing the depressive effect of opioids on the respiratory center can be administered. SUMMARY. This work collects the most important and up-to-date information on designer drugs, based on reports and articles published between 2015 and 2019. The covered aspects include: the current definition of designer drugs in relation to the Polish law, their exact division due to the clinical effects they cause and the description of the threats they pose. Emphasis was given to the current situation of the designer drug market in Poland.
Authors and Affiliations
Emil Bartosz Rozenek, Karolina Wilczyńska, Monika Górska, Napoleon Waszkiewicz
Keywords
Related Articles
- EP ID EP670189
- DOI 10.32394/pe.73.23
- Views 243
- Downloads 0
Sick people and sick populations – legacy of Geoffrey Rose
Developed by Geoffrey Rose strategy of preventive medicine caused a major breakthrough in thinking about the effectiveness of preventive measures. The distinction between actions within the high-risk groups against activ...
Epidemiologia zakażeń HCV w Europie Środkowej i Południowo-Wschodniej
CELEM PRACY jest oszacowanie rozpowszechnienia zakażeń HCV w 14 krajach Europy Środkowej i Wschodniej. MATERIAŁ I METODY. W pracy zaprezentowano dane porównawcze dotyczące osób, u których wykryto obecność przeciwciał ant...
Yersiniosis in Poland in 2015 and 2016 / Jersinioza w Polsce w 2015 i 2016 roku
OBJECTIVE. The aim of this study is to assess the epidemiological situation of yersiniosis in Poland in 2015 and 2016 in comparison to the previous years. MATERIAL AND METHODS. The evaluation is based on analysis of data...
Lyme disease in Poland in 2015 / Borelioza z Lyme w Polsce w 2015 roku
INTRODUCTION: Lyme disease is the most common tick-borne disease in Poland. Borrelia burgdorferi spirochete can occur in the whole country, which, according to ECDC, should be considered as an endemic area. Borrelia stra...
Effectivity of antiseptics against some pathogens
INTRODUCTION. The efficacy of antiseptics against bacteria and fungi is different. The choice of optimal antiseptic solution is very important in prophylaxis of hospital infections. MATERIAL AND METHODS. In this study th...